loadpatents
name:-0.044087886810303
name:-0.031301975250244
name:-0.0081100463867188
Coito; Carlos Patent Filings

Coito; Carlos

Patent Applications and Registrations

Patent applications and USPTO patent grants for Coito; Carlos.The latest application filed is for "treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf".

Company Profile
6.35.42
  • Coito; Carlos - West Palm Beach FL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)
Grant 11,408,004 - Collard , et al. August 9, 2
2022-08-09
Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
Grant 11,390,868 - Collard , et al. July 19, 2
2022-07-19
Treatment Of Glial Cell Derived Neurotrophic Factor (gdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Gdnf
App 20220195439 - Collard; Joseph ;   et al.
2022-06-23
Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
Grant 10,995,334 - Collard , et al. May 4, 2
2021-05-04
Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA
Grant 10,793,857 - Collard , et al. October 6, 2
2020-10-06
Treatment Of Glial Cell Derived Neurotrophic Factor (gdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Gdnf
App 20200291407 - COLLARD; Joseph ;   et al.
2020-09-17
Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
Grant 10,604,755 - Collard , et al.
2020-03-31
Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
Grant 10,519,448 - Collard , et al. Dec
2019-12-31
Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
Grant 10,465,192 - Collard , et al. No
2019-11-05
Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
Grant 10,435,690 - Collard , et al. O
2019-10-08
Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
Grant 10,214,745 - Faghihi , et al. Feb
2019-02-26
Treatment Of Glial Cell Derived Neurotrophic Factor (gdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Gdnf
App 20190040394 - COLLARD; Joseph ;   et al.
2019-02-07
Treatment Of Filaggrin (flg) Related Diseases By Modulation Of Flg Expression And Activity
App 20190024084 - Collard; Joseph ;   et al.
2019-01-24
Treatment of filaggrin (FLG) related diseases by modulation of FLG expression and activity
Grant 10,113,166 - Collard , et al. October 30, 2
2018-10-30
Treatment Of Alpha-l-iduronidase (idua) Related Diseases By Inhibition Of Natural Antisense Transcript To Idua
App 20180135050 - COLLARD; Joseph ;   et al.
2018-05-17
Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG
Grant 9,902,958 - Collard , et al. February 27, 2
2018-02-27
Treatment Of Delta-like 1 Homolog (dlk1) Related Diseases By Inhibition Of Natural Antisense Transcript To Dlk1
App 20180051286 - COLLARD; Joseph ;   et al.
2018-02-22
Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
Grant 9,873,873 - Collard , et al. January 23, 2
2018-01-23
Treatment Of Sodium Channel, Voltage-gated, Alpha Subunit (scna) Related Diseases By Inhibition Of Natural Antisense Transcript To Scna
App 20180002696 - COLLARD; Joseph ;   et al.
2018-01-04
Treatment Of Sodium Channel, Voltage-gated, Alpha Subunit (scna) Related Diseases By Inhibition Of Natural Antisense Transcript To Scna
App 20170355990 - COLLARD; Joseph ;   et al.
2017-12-14
Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
Grant 9,834,769 - Collard , et al. December 5, 2
2017-12-05
Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA
Grant 9,771,579 - Collard , et al. September 26, 2
2017-09-26
Treatment Of Glial Cell Derived Neurotrophic Factor (gdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Gdnf
App 20170226516 - COLLARD; Joseph ;   et al.
2017-08-10
Treatment of `C terminus of HSP7O-interacting protein` (CHIP) related diseases by inhibition of natural antisense transcript to CHIP
Grant 9,725,756 - Collard , et al. August 8, 2
2017-08-08
Treatment Of Brain Derived Neurotrophic Factor (bdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Bdnf
App 20170211071 - Faghihi; Mohammad Ali ;   et al.
2017-07-27
Treatment of delta-like 1 homolog (DLK1) related diseases by inhibition of natural antisense transcript to DLK1
Grant 9,708,604 - Collard , et al. July 18, 2
2017-07-18
Treatment Of Nuclear Factor (erythroid-derived 2)-like 2 (nrf2) Related Diseases By Inhibition Of Natural Antisense Transcript To Nrf2
App 20170145411 - COLLARD; Joseph ;   et al.
2017-05-25
Treatment of `IQ motif containing gtpase activating protein` (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP
Grant 9,528,110 - Collard , et al. December 27, 2
2016-12-27
Treatment of nuclear factor (erythroid-derived 2)-like 2 (NRF2) related diseases by inhibition of natural antisense transcript to NRF2
Grant 9,464,287 - Collard , et al. October 11, 2
2016-10-11
Treatment Of Discs Large Homolog (dlg) Related Diseases By Inhibition Of Natural Antisense Transcript To Dlg
App 20160281088 - COLLARD; Joseph ;   et al.
2016-09-29
Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG
Grant 9,394,542 - Collard , et al. July 19, 2
2016-07-19
Treatment Of Brain Derived Neurotrophic Factor (bdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Bdnf
App 20160138023 - Collard; Joseph ;   et al.
2016-05-19
Treatment Of Alpha-l-iduronidase (idua) Related Diseases By Inhibition Of Natural Antisense Transcript To Idua
App 20160130584 - COLLARD; Joseph ;   et al.
2016-05-12
Treatment Of Delta-like 1 Homolog (dlk1) Related Diseases By Inhibition Of Natural Antisense Transcript To Dlk1
App 20160090599 - COLLARD; JOSEPH ;   et al.
2016-03-31
Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUA
Grant 9,222,088 - Collard , et al. December 29, 2
2015-12-29
Treatment Of Interferon-related Developmental Regulator 1 (ifrd1) Related Diseases By Inhibition Of Natural Antisense Transcript To Ifrd1
App 20150368644 - COLLARD; Joseph ;   et al.
2015-12-24
Treatment Of Sirtuin (sirt) Related Diseases By Inhibition Of Natural Antisense Transcript To A Sirtuin (sirt)
App 20150284724 - COLLARD; Joseph ;   et al.
2015-10-08
Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT)
Grant 9,089,588 - Collard , et al. July 28, 2
2015-07-28
Treatment Of 'iq Motif Containing Gtpase Activating Protein' (iqgap) Related Diseases By Inhibition Of Natural Antisense Transcript To Iqgap
App 20150197750 - COLLARD; Joseph ;   et al.
2015-07-16
Treatment of brain derived neurotrophic factor (BDNF) related diseases by inhibition of natural antisense transcript to BDNF
Grant 9,074,210 - Collard , et al. July 7, 2
2015-07-07
Treatment Of Filaggrin (flg) Related Diseases By Modulation Of Flg Expression And Activity
App 20150152417 - COLLARD; JOSEPH ;   et al.
2015-06-04
Treatment Of Discs Large Homolog (dlg) Related Diseases By Inhibition Of Natural Antisense Transcript To Dlg
App 20150133526 - COLLARD; Joseph ;   et al.
2015-05-14
Treatment of 'IQ motif containing GTPase activating protein' (IQGAP) related diseases by inhibition of natural antisense transcript to IQGAP
Grant 9,023,822 - Collard , et al. May 5, 2
2015-05-05
Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLG
Grant 8,980,860 - Collard , et al. March 17, 2
2015-03-17
Treatment Of Brain Derived Neurotrophic Factor (bdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Bdnf
App 20150031750 - Faghihi; Mohammad Ali ;   et al.
2015-01-29
Treatment Of 'c Terminus Of Hsp70-interacting Protein' (chip) Related Diseases By Inhibition Of Natural Antisense Transcript To Chip
App 20140288152 - COLLARD; Joseph ;   et al.
2014-09-25
Treatment of `C terminus of HSP70-interacting protein` (CHIP)related diseases by inhibition of natural antisense transcript to CHIP
Grant 8,791,087 - Collard , et al. July 29, 2
2014-07-29
Treatment Of Alpha-l-iduronidase (idua) Related Diseases By Inhibition Of Natural Antisense Transcript To Idua
App 20130253036 - Collard; Joseph ;   et al.
2013-09-26
Treatment Of Interferon-related Developmental Regulator 1 (ifrd1) Related Diseases By Inhibition Of Natural Antisense Transcript To Ifrd1
App 20130210893 - Collard; Joseph ;   et al.
2013-08-15
Treatment Of Discs Large Homolog (dlg) Related Diseases By Inhibition Of Natural Antisense Transcript To Dlg
App 20130143946 - Collard; Joseph ;   et al.
2013-06-06
Treatment Of Glial Cell Derived Neurotrophic Factor (gdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Gdnf
App 20130137751 - COLLARD; JOSEPH ;   et al.
2013-05-30
Treatment Of Sodium Channel, Voltage-gated, Alpha Subunit (scna) Related Diseases By Inhibition Of Natural Antisense Transcript To Scna
App 20130096183 - Collard; Joseph ;   et al.
2013-04-18
Treatment Of Sirtuin (sirt) Related Diseases By Inhibition Of Natural Antisense Transcript To A Sirtuin (sirt)
App 20130072421 - Collard; Joseph ;   et al.
2013-03-21
Treatment of hemoglobin (HBF/HBG) related diseases by inhibition of natural antisense transcript to HBF/HBG
Grant 8,318,690 - Collard , et al. November 27, 2
2012-11-27
Treatment Of Filaggrin (flg) Related Diseases By Modulation Of Flg Expression And Activity
App 20120295952 - Collard; Joseph ;   et al.
2012-11-22
Treatment Of 'iq Motif Containing Gtpase Activating Protein' (iqgap) Related Diseases By Inhibition Of Natural Antisense Transcript To Iqgap
App 20120142610 - Collard; Joseph ;   et al.
2012-06-07
Treatment Of 'c Terminus Of Hsp70-interacting Protein' (chip) Related Diseases By Inhibition Of Natural Antisense Transcript To Chip
App 20120135941 - Collard; Joseph ;   et al.
2012-05-31
Treatment Of Nuclear Factor (erythroid-derived 2)-like 2 (nrf2) Related Diseases By Inhibition Of Natural Antisense Transcript To Nrf2
App 20120004184 - Collard; Joseph ;   et al.
2012-01-05
Treatment Of Brain Derived Neurotrophic Factor (bdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Bdnf
App 20110319475 - Collard; Joseph ;   et al.
2011-12-29
Treatment Of Glial Cell Derived Neurotrophic Factor (gdnf) Related Diseases By Inhibition Of Natural Antisense Transcript To Gdnf
App 20110319476 - Collard; Joseph ;   et al.
2011-12-29
Treatment Of Sirtuin 1 (sirt1) Related Diseases By Inhibition Of Natural Antisense Transcript To Sirt1
App 20110319317 - Collard; Joseph ;   et al.
2011-12-29
Treatment Of Sirtuin 1 (sirt1) Related Diseases By Inhibition Of Natural Antisense Transcript To Sirtuin 1
App 20110237649 - Collard; Joseph ;   et al.
2011-09-29
Treatment Of Hemoglobin (hbf/hbg) Related Diseases By Inhibition Of Natural Antisense Transcript To Hbf/hbg
App 20100280100 - COLLARD; Joseph ;   et al.
2010-11-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed